My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 114

    1.

    Intravitreal bevacizumab therapy for neovascular age-related macular degeneration associated with poor initial visual acuity.

    Galbinur T, Averbukh E, Banin E, Hemo I, Chowers I.

    Br J Ophthalmol. 2009 Oct;93(10):1351-2. Epub 2009 Jun 10.PMID: 19520693 [PubMed - indexed for MEDLINE]Related articles

    2.

    Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

    Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.

    Retina. 2007 Apr-May;27(4):432-8.PMID: 17420694 [PubMed - indexed for MEDLINE]Related articles

    3.

    Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration.

    Emerson MV, Lauer AK, Flaxel CJ, Wilson DJ, Francis PJ, Stout JT, Emerson GG, Schlesinger TK, Nolte SK, Klein ML.

    Retina. 2007 Apr-May;27(4):439-44.PMID: 17420695 [PubMed - indexed for MEDLINE]Related articles

    4.

    Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration.

    Kaiser PK; Registry of Visudyne AMD Therapy Writing Committee, Boyer DS, Garcia R, Hao Y, Hughes MS, Jabbour NM, Kaiser PK, Mieler W, Slakter JS, Samuel M, Tolentino MJ, Roth D, Sheidow T, Strong HA.

    Ophthalmology. 2009 Apr;116(4):747-55, 755.e1. Epub 2009 Feb 25.PMID: 19243834 [PubMed - indexed for MEDLINE]Related articles

    5.

    Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.

    Arevalo JF, Fromow-Guerra J, Sanchez JG, Maia M, Berrocal MH, Wu L, Saravia MJ, Costa RA; Pan-American Collaborative Retina Study Group.

    Retina. 2008 Nov-Dec;28(10):1387-94.PMID: 18827735 [PubMed - indexed for MEDLINE]Related articles

    6.

    Same-day triple therapy with photodynamic therapy, intravitreal dexamethasone, and bevacizumab in wet age-related macular degeneration.

    Bakri SJ, Couch SM, McCannel CA, Edwards AO.

    Retina. 2009 May;29(5):573-8.PMID: 19430278 [PubMed - indexed for MEDLINE]Related articles

    7.

    Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration using a variable frequency regimen in eyes with no previous treatment.

    Fong KC, Kirkpatrick N, Mohamed Q, Johnston RL.

    Clin Experiment Ophthalmol. 2008 Nov;36(8):748-55.PMID: 19128380 [PubMed - indexed for MEDLINE]Related articles

    8.

    A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations.

    Algvere PV, Steén B, Seregard S, Kvanta A.

    Acta Ophthalmol. 2008 Aug;86(5):482-9. Epub 2007 Dec 14.PMID: 18162062 [PubMed - indexed for MEDLINE]Related articles

    9.

    Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections.

    Melamud A, Stinnett S, Fekrat S.

    Am J Ophthalmol. 2008 Jul;146(1):91-5. Epub 2008 May 2.PMID: 18455144 [PubMed - indexed for MEDLINE]Related articles

    10.

    Visual improvement following intravitreal bevacizumab (Avastin) in exudative age-related macular degeneration.

    Yoganathan P, Deramo VA, Lai JC, Tibrewala RK, Fastenberg DM.

    Retina. 2006 Nov-Dec;26(9):994-8.PMID: 17151485 [PubMed - indexed for MEDLINE]Related articles

    11.

    Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage.

    Stifter E, Michels S, Prager F, Georgopoulos M, Polak K, Hirn C, Schmidt-Erfurth U.

    Am J Ophthalmol. 2007 Dec;144(6):886-892. Epub 2007 Oct 4.PMID: 17916314 [PubMed - indexed for MEDLINE]Related articles

    12.

    Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

    Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ.

    Ophthalmology. 2006 Mar;113(3):363-372.e5. Epub 2006 Feb 3.PMID: 16458968 [PubMed - indexed for MEDLINE]Related articles

    13.

    Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

    Rich RM, Rosenfeld PJ, Puliafito CA, Dubovy SR, Davis JL, Flynn HW Jr, Gonzalez S, Feuer WJ, Lin RC, Lalwani GA, Nguyen JK, Kumar G.

    Retina. 2006 May-Jun;26(5):495-511.PMID: 16770255 [PubMed - indexed for MEDLINE]Related articles

    14.

    Intravitreal bevacizumab therapy for neovascular age-related macular degeneration: a pilot study.

    Abrahám-Marin ML, Cortés-Luna CF, Alvarez-Rivera G, Hernández-Rojas M, Quiroz-Mercado H, Morales-Cantón V.

    Graefes Arch Clin Exp Ophthalmol. 2007 May;245(5):651-5. Epub 2006 Sep 28.PMID: 17006681 [PubMed - indexed for MEDLINE]Related articles

    15.

    Efficacy of intravitreal bevacizumab (Avastin) therapy for early and advanced neovascular age-related macular degeneration.

    Krebs I, Lie S, Stolba U, Zeiler F, Felke S, Binder S.

    Acta Ophthalmol. 2009 Sep;87(6):611-7. Epub 2009 Oct 17.PMID: 18937801 [PubMed - indexed for MEDLINE]Related articles

    16.

    Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study.

    Weigert G, Michels S, Sacu S, Varga A, Prager F, Geitzenauer W, Schmidt-Erfurth U.

    Br J Ophthalmol. 2008 Mar;92(3):356-60.PMID: 18303156 [PubMed - indexed for MEDLINE]Related articles

    17.

    Treatment of choroidal neovascularization using intravitreal bevacizumab.

    Pedersen R, Soliman W, Lund-Andersen H, Larsen M.

    Acta Ophthalmol Scand. 2007 Aug;85(5):526-33. Epub 2007 May 18.PMID: 17511757 [PubMed - indexed for MEDLINE]Related articles

    18.

    Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP).

    Konstantinidis L, Mameletzi E, Mantel I, Pournaras JA, Zografos L, Ambresin A.

    Graefes Arch Clin Exp Ophthalmol. 2009 Sep;247(9):1165-71. Epub 2009 Apr 29.PMID: 19404661 [PubMed - indexed for MEDLINE]Related articles

    19.

    Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.

    Ahmadieh H, Taei R, Soheilian M, Riazi-Esfahani M, Karkhaneh R, Lashay A, Azarmina M, Dehghan MH, Moradian S.

    BMC Ophthalmol. 2007 Jun 7;7:10.PMID: 17555600 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Predictive factors of visual and anatomical outcome after intravitreal bevacizumab treatment of neovascular age-related macular degeneration: an optical coherence tomography study.

    Singh RP, Fu EX, Smith SD, Williams DR, Kaiser PK.

    Br J Ophthalmol. 2009 Oct;93(10):1353-8. Epub 2009 Jun 24.PMID: 19556212 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity